[Desensitization with sulfadiazine in a patient with cerebral toxoplasmosis refractory to alternative treatment].
Campany
D
D
Sales
P
P
Grau
S
S
Saballs
P
P
Drobnic
L
L
Gimeno
J L
JL
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000328:Adult; D000818:Animals; D003888:Desensitization, Immunologic; D003875:Drug Eruptions / Q000209:etiology / Q000628:therapy*; D004351:Drug Resistance; D005260:Female; D006801:Humans; D013411:Sulfadiazine / Q000009:adverse effects / Q000276:immunology / Q000494:pharmacology / Q000627:therapeutic use*; D014122:Toxoplasma / Q000187:drug effects; D016781:Toxoplasmosis, Cerebral / Q000188:drug therapy*
D013411:Sulfadiazine
Desensibilización con sulfadiazina en un paciente con toxoplasmosis cerebral refractaria al tratamiento alternativo.